MDWD241220C25000
- 0.80
- 0.000.00%
MediWound Newsroom
MediWound Advances With FDA Approval and New Funding
MediWound GAAP EPS of -$0.98 Misses by $0.53, Revenue of $4.35M Misses by $1.66M
MediWound | 6-K: Report of foreign private issuer (related to financial reporting)
Earnings Flash (MDWD) MEDIWOUND Posts Q3 Revenue $4.4M, Vs. Street Est of $6.0M
Express News | Mediwound : Anticipates $20 Mln in Total Revenue for 2024
Express News | Mediwound Q3 Gross Profit USD 700 Thousand
MediWound 3Q Loss $26.3M >MDWD
MediWound 3Q Loss/Shr 98c >MDWD
Earnings Scheduled For November 26, 2024
Here's the Major Earnings Before the Open Tomorrow
Earnings Preview: MediWound
Earnings Preview: MediWound to Report Financial Results Pre-market on November 26
$MediWound(MDWD.US)$ is scheduled to release its financial results pre-market on November 26 ET. Earnings PreviewAnalysts estimate $MediWound(MDWD.US)$ to post revenue of USD6.01M for 2024Q3, up 25.76
MediWound to Discuss New Share Incentive Plan
MediWound to Report Third Quarter 2024 Financial Results
MediWound's (NASDAQ:MDWD) Investors Will Be Pleased With Their Stellar 125% Return Over the Last Year
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $28
MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
MediWound Analyst Ratings